Cite
Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer.
MLA
Wilson, Andrew J., et al. “Panobinostat Enhances Olaparib Efficacy by Modifying Expression of Homologous Recombination Repair and Immune Transcripts in Ovarian Cancer.” Neoplasia, vol. 24, no. 2, Feb. 2022, pp. 63–75. EBSCOhost, https://doi.org/10.1016/j.neo.2021.12.002.
APA
Wilson, A. J., Gupta, V. G., Liu, Q., Yull, F., Crispens, M. A., & Khabele, D. (2022). Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer. Neoplasia, 24(2), 63–75. https://doi.org/10.1016/j.neo.2021.12.002
Chicago
Wilson, Andrew J., Vijayalaxmi G Gupta, Qi Liu, Fiona Yull, Marta A. Crispens, and Dineo Khabele. 2022. “Panobinostat Enhances Olaparib Efficacy by Modifying Expression of Homologous Recombination Repair and Immune Transcripts in Ovarian Cancer.” Neoplasia 24 (2): 63–75. doi:10.1016/j.neo.2021.12.002.